Zhuhai Yufan Biotechnologies Co.

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Zhuhai Yufan Biotechnologies Co. sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials none currently recruiting early-phase tilt upper half by trial count

Zhuhai Yufan Biotechnologies Co.: 1 sponsored US clinical trial, none currently recruiting.

Zhuhai Yufan Biotechnologies Co. sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Advanced Solid Malignancies, with 1 trials.

Mid-pack sponsor footprint

Zhuhai Yufan Biotechnologies Co. is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

How the Zhuhai Yufan Biotechnologies Co. early-phase archive is shaped

1 indexed studies, none listed as recruiting (0% open).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Advanced Solid Malignancies (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Zhuhai Yufan Biotechnologies Co.: archived-pipeline peers nationwide

Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Zhuhai Yufan Biotechnologies Co. sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Zhuhai Yufan Biotechnologies Co.1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Zhuhai Yufan Biotechnologies Co. sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Zhuhai Yufan Biotechnologies Co. sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Zhuhai Yufan Biotechnologies Co. page

1 registered trials is a research-attention snapshot, not an endorsement of Zhuhai Yufan Biotechnologies Co. or any single study.

  • None of Zhuhai Yufan Biotechnologies Co.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Advanced Solid Malignancies is the condition Zhuhai Yufan Biotechnologies Co. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Advanced Solid Malignancies trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Zhuhai Yufan Biotechnologies Co. pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.